Pharmaceutical

Takeda licensed for anaemia therapy by Keros Therapeutics

Takeda has signed an agreement to receive an exclusive global licence from Keros Therapeutics for elritercept.

Dec 5, 2024 - 06:00
Takeda licensed for anaemia therapy by Keros Therapeutics
Takeda has signed an agreement to receive an exclusive global licence from Keros Therapeutics for elritercept.
Read the original article

Tags:

Previous Article

Ipsen and Biomunex enter agreement for cancer therapy

Next Article

All-in-one milling platforms: How to reduce your machinery footprint  

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Defunding liberal arts is dangerous for health care

Opinion: Defunding liberal arts is dangerous for health...

Jan 24, 2024

Cara Therapeutics cuts 50% of staff and drops kidney disease program

Cara Therapeutics cuts 50% of staff and drops kidney di...

Jan 23, 2024

STAT+: FDA removes neurologist with financial ties to Eisai and Biogen from Alzheimer’s advisory panel

STAT+: FDA removes neurologist with financial ties to E...

Jun 6, 2023